About the Sleep CAG
The Surrey Clinical Research Centre (CRC) is a core human research resource within the Faculty of Health & Medical Sciences, University of Surrey. The Surrey CRC is an MHRA Phase I accredited unit (supplementary accreditation) with a wealth of experience in undertaking Phase I and IIa clinical trials. We are the European partner of choice with many Sponsors in undertaking early phase studies. We cover all aspects of trial design, set-up, trial conduct, data management, data analysis and reporting from single-site to global multi-centre trials.
Safety and quality are at the forefront of our work. Working with our leading experts we ensure the timely delivery of accurate solutions to help our clients achieve faster and better informed decision-making. This also provides the assurance that our volunteers and patients have a rewarding experience during their time with us.
The Clinical Research Facility is a specialist clinical pharmacology unit housing a 12-bed ward and 12 individual bedrooms in a purpose-designed building, adjacent to the Royal Surrey County Hospital. Since 1999 we have provided industry-leading services to pharmaceutical companies for trials at all stages from Phase I, first-in-human, through to Phase IV patient trials. In addition to our work with leading pharmaceutical companies we collaborate with small biotech organisations, charitable organisations, basic science and clinical academic colleagues on a range of studies including CTIMP, medical device and interventional studies.
We employ several full-time pharmaceutical physicians and have a substantial clinical team of RGN nurses who oversee the conduct of all our studies.
The Clinical Trials Unit provides expertise to support the design, management and analysis of global multi-centre trials. The CTU has a full service electronic data capture (Promasys) that supports remote randomisation and eCRF completion. The team of highly trained staff undertake trial management and governance activities including trial coordination, data management, analysis, trial monitoring and pharmacovigilance.
We have a prestigious track record of over 15 years’ experience undertaking clinical trials in both volunteer and patient populations.
Particular areas of strength include our ability to design and execute Phase I and IIa trials in sleep, oncology and clinical vaccinology. In addition, our unique through-the-wall cannulation system allows PK/PD sampling over a 24 hour period without disturbing the sleep profile of our subjects. This enables accurate biomarker profiles to be obtained across the circadian phase without confounding values through sleep disturbance and physiological stress.